Pharmaceutical Lipids Market - Global Industry Analysis, Market Size, Opportunities and Forecast 2021 - 2028

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Forthcoming | Report ID : ARC2767

Lipids are widely used as fillers, binders, lubricants, solubilizers, emulsifiers, and emollients for delivery of drugs. The most important function of lipids is to play as cell membrane transport agents in cell membrane.

Market Dynamics

Pharmaceutical sector across the globe is witnessing rapid growth. With the rising investment in the sector and high R&D activities taking place across developed and developing countries for new drug development. The industry is observing high growth. According to the Pharmaceutical Research and Manufacturers Association (PhRMA), U.S. firms conduct over half the world's R&D in pharmaceuticals US$ 75 Bn and hold the intellectual property rights on most new medicines. Lipids are widely used as fillers, binders, lubricants, solubilizers, emulsifiers, and emollients for delivery of drugs. Flourishing cosmetic sector across the globe and high demand from cosmetic sector for lipid solutions as ingredients are major factors expected to drive the growth of global pharmaceutical lipids market. Major players are investing high for product development activities their approach towards enhancing the business through product launch and acquisition is expected to augment the growth of global pharmaceutical lipids market.

In 2021, Merck, a global biopharmaceutical service provider launched a new high-purity synthetic cholesterol product “SAFC”. The product launch is expected to help the company enhance the business and increase the revenue share.

In 2020, Croda International Plc, a global pharmaceutical company acquired Avanti Polar Lipids, Inc. The acquisition was focused to enhance the company’s product portfolio of lipid-based drug delivery technologies for next generation pharmaceuticals. This is expected to help Croda to enhance the product offering and increase the revenue share.

Covid-19 pandemic on its peak and high investment form public and private players for development of vaccines is resulting in players approach towards ramping up the production of lipids to care the growing needs. This is expected to impact the growth of target market. In 2021, MilliporeSigma, a global manufacturer of lipids increased its production capacity by 50 times, helping biomanufacturers bring lifesaving therapies to patients faster. MilliporeSigma is collaborating with more than 50 companies to support their efforts in the development and production of Covid-19 vaccines and treatments, providing custom lipids, as well as other critical raw materials, processing equipment and services used in mRNA drugs and vaccines manufacturing. Factors such as high cost associated to R&D activities and stringent government regulations related to product approval are expected to hamper the growth of global pharmaceutical lipids market. In addition, lack of developed infrastructure in developing countries is expected to limit the R&D activities further challenging the growth of target market. However, increasing government spending on development of healthcare sector and introduction of new products are factors expected to create new opportunities for players operating in the pharmaceutical lipids market over the forecast period. In addition, increasing partnership and agreements between regional and international players is expected to support the revenue transaction of the target market.

Segment Analysis by Region

The market in North America is expected to account for major revenue share in the global pharmaceutical lipids market due to high government spending on drug development. Availability of advanced infrastructure for R&D activities and presence of large number of players operating in the country are factors expected to support the market growth. In addition, major players approach towards business expansion through acquisitions is expected to boost the market growth.

Competitive Landscape      

The global pharmaceutical lipids market is highly competitive due to presence of large number of players and innovative product offerings. In addition, business expansion activities through partnerships and agreements are factors expected to further increase the competition.

Report coverage

Market

Global Wine Market

Analysis Period

2017 – 2028

Base Year

2020

Forecast Data

2021 – 2028

Market Stratification

Product, Form, Source, Application, and Geography

Regional Scope

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

Report Coverage

Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis


Pharmaceutical Lipids Market Segment Analysis, 2020

The global pharmaceutical lipids market is segmented into product, form, source and application. The product segment is divided into triglycerides, phospholipids, sphingolipids, cholesterol, fatty acids, and others. Among product the triglycerides segment is expected to account for major revenue share in the global pharmaceutical lipids market. The application segment is divided into conventional lipid-based drug delivery systems, self-emulsifying drug delivery systems, self-microemulsifying drug delivery systems, liposomes, solid lipid nanoparticles, nanostructured lipid carriers, and others. Players operating in the global pharmaceutical lipids market are ABITEC Corporation, Nippon Oil & Fats Corporation, Lipoid GmbH, Nippon Fine Chemical Co. Ltd., BASF SE, Dishman Group, Cayman Chemical Company, CordenPharma, Croda International Plc, Gattefossé, IOI Oleo GmbH, Merck KGaA, Stepan Company, and Evonik Industries AG.

Market Segmentation

Market By Product

Triglycerides
Phospholipids
Sphingolipids
Cholesterol
Fatty Acids
Others

Market By Form

Liquid Pharmaceutical Lipids
Semi-solid Pharmaceutical Lipids
Solid Pharmaceutical Lipids

Market By Source

Synthetic Pharmaceutical Lipids
Semi-synthetic Pharmaceutical Lipids
Natural Pharmaceutical Lipids

Market By Application

Conventional Lipid-based Drug Delivery Systems
Self-Emulsifying Drug Delivery Systems
Self-Microemulsifying Drug Delivery Systems
Liposomes
Solid Lipid Nanoparticles
Nanostructured Lipid Carriers
Others

Market By Geography

North America
•    U.S.
•    Canada

Europe
•    U.K.
•    Germany
•    France
•    Spain
•    Rest of Europe

Asia-Pacific
•    China
•    Japan
•    India
•    Australia
•    South Korea
•    Rest of Asia-Pacific

Latin America
•    Brazil 
•    Mexico
•    Rest of Latin America

Middle East & Africa
•    GCC
•    South Africa
•    Rest of Middle East & Africa

Frequently Asked Questions

Flourishing cosmetic sector across the globe and high demand from cosmetic sector for lipid solutions as ingredients are major factors expected to drive the growth of global pharmaceutical lipids market.

In product the triglycerides segment is growing at faster pace.

In the global market the Asia Pacific region is expected to grow faster.

Some of the players considered in the report scope are Nippon Oil & Fats Corporation, Lipoid GmbH, Nippon Fine Chemical Co. Ltd., BASF SE, and Dishman Group.

The North America is expected to account for major revenue share in the global market.

Factors such as high cost associated to R&D activities and stringent government regulations related to product approval are expected to hamper the growth of global pharmaceutical lipids market.

Cart Summary